1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2018The Kiplinger Washington Editors
Our picks for closed-end stock and bond funds should appeal
to yield-starved investors.
These three closed-end funds look cheap compared with the value of their underlying holdings.
According to top analysts on the Street, these five “Strong Buy” biotech stocks are primed for outsized growth in the next 12 months.
Biotechs often present intriguing, and potentially...
More Investing News »